Human B cells secreting immunoglobulin G to glutamic acid decarboxylase- 65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: A comparison with those present in type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2664-2670

  Tremble, Jennifer ^a   Morgenthaler, Nils G ^a,d   Vlug, Arjen ^b   Powers, Alvin C ^c   Christie, Michael R ^a   Scherbaum, Werner A ^d   Banga, J Paul ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CENTRAL LABORATORY   (Netherlands)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G;

ARTICLE; AUTOIMMUNITY; CHIMERA; EPSTEIN BARR VIRUS; GRAVES DISEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; STIFF MAN SYNDROME;

ADULT; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUTAMATE DECARBOXYLASE; GRAVES DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; ISLETS OF LANGERHANS; MALE; PEPTIDES; TRYPSIN;

HUMAN HERPESVIRUS 4;

EID: 0030838447     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2664     Document Type: Article

References (38)

1. Christie MR. 1996 Antibodies to glutamic acid decarboxylase in the prediction of insulin dependent diabetes. In: Palmer J, ed. Diabetes; prediction, prevention and genetic councelling. Chichester: Wiley and Sons; 77-96.
2. Seissler J, Amann J, Mauch L, et al. 1993 Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin dependent diabetes mellitus. J Clin Invest. 92:1394-1399.
3. Velloso LA, Kampe O, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA. 1993 Demonstration of GAD65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eucaryotic expression. J Clin Invest. 92:2084-2090.
4. Grubin CE, Daniels T, Toivola B, et al.. 1994 A novel radioligand binding assay to determine the diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37:344-350.
5. Bingley PJ, Christie MR, Bonifacio E, et al. 1994 Combined analysis of autoantibody improves prediction of IDDM in islet cell antibody positive relatives. Diabetes. 43:1304-1310.
6. Seissler J, Morgenthaler N, Achenbach P, et al. 1996 Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives odf patients with IDDM. Diabetologia. 39:1351-1356.
7. Falorni A, Grubin C, Takei I, et al. 1994 Radioimmunoassay detects the frequent occurance of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity. 19:113-125.
8. Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers AC. 1994 Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes. 43:968-975.
9. Solimena M, Folli F, Denis-Donini S, et al. 1988 1988 Autoantibodies to glutamic acid decarboxylase in a patient with stiff man syndrome, epilepsy and type 1 diabetes. N Engl J Med. 318:1012-1020.
10. Butler MH, Solimena M, Dirkx R, Hayday A, De Camilli P. 1993 Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med. 178:2097-2106.
11. Mauch L, Abney CC, Berg H, Scherbaum WA, Liedvogel B, Northemann W. 1993 Characterisation of a linear epitope within the human pancreatic 64kD glutamic acid decarboxylase and its autoimmune recognition by sera from insulin dependent diabetes mellitus patients. Eur J Biochem. 212:597-603.
12. 2-terminal epitope in the autoantigen GAD65 distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med. 180:595-606.
13. Li L, Hagopian WA, Brashear R, Daniels T, Lernmark A. 1994 Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff man syndrome patients. J Immunol. 152:930-934.
14. Richter W, Shi Y, Baekkeskov S. 1993 Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA. 90:2832-2836.
15. Daw K, Powers AC. 1995 Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes. 44:216-220.
16. Falorni A, Ackefors M, Carlberg C, et al. 1996 Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia. 39:1091-1098.
17. Christie MR, Genovese S, Cassidy D, et al. 1994 Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes. 43:1254-1259.
18. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. 1990 Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med. 322:1555-1560.
19. Banga JP, McGregor AM. 1991 Enzymes as targets for autoantibodies in human autoimmune disease: relevance to pathogenesis. Autoimmunity. 9:177-182.
20. Bjork E, Velloso LA, Kampe O, Karlsson A. 1994 GAD autoantibodies in IDDM, stiff man syndrome and autoimmune polyendocrine syndrom type 1 recognise different epitopes. Diabetes. 43:161-165.
21. Velloso LA, Winqvist O, Gustafsson J, Kampe O, Karlsson FA. 1994 Autoantibodies against a novel 51kD islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type 1. Diabetologia. 37:61-69.
22. Tuomi T, Bjorses P, Falorni A, et al. 1996 antibodies to glutamic acid decarboxylase and insulin dependent diabetes in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 81:1488-1494.
23. Richter W, Endl J, Eiermann TH, et al. 1992 Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA. 89:8467-8471.
24. Syren K, Lindsay L, Stoehrer B, et al. 1996 Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol. 157:5208-5214.
25. Richter W, Northemann W, Muller M, Boehm BO. 1996 Mapping of an autoreactive epitope within glutamate decarboxylase using a diabetes-associated human monoclonal autoantibody and an epitope cDNA library. Hybridoma. 15:103-108.
26. Madec AM, Rousset F, Ho S, et al. 1996 Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognise distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated. J Immunol. 156:3541-3549.
27. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. 1995 Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med. 181:1957-1963.
28. Bosi E, Becker F, Bonifacio E, et al. 1991 Progression to type 1 diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes. 40:977-984.
29. Morgenthaler NG, Kim MR, Tremble J, et al. 1996 Human IgG autoantibodies to the thyrotropin receptor from Epstein Barr virus transformed B lymphocytes: characterisation by immunoprecipitation with recombinant antigen and biological activity. J Clin Endocrinol Metab. 81:3155-3161.
30. Petersen JS, Hejnaes KR, Moody A, et al. 1994 Detection of GAD65 antibodies in diabetes and other autoimmune diseases using simple a radioligand assay. Diabetes. 43:459-467.
31. Moody AJ, Hejnaes KR, Marshall MO, et al. 1995 Isolation by anion exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells. Diabetologia. 38:14-23.
32. Scherbaum WA, Mirakian R, Pujol-Borrell R, Dean BM, Bottazzo GF. 1986 Immunocytochemistry in the study and diagnosis of organ specific autoimmune disease. In: Polak JM, Van Noorden S, eds. Immunocytochemistry. Modern methods and applications. Bristol: Wright; 456-476.
33. Vlug A, Nieuwenhuys EJ, van Eijk RVW, Geertzen HGM, van Houte AJ. 1994 Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin. 52:561-567.
34. Bredius RGM, Driedijk PC, Schouten MF, Weening RS, Out TA. 1992 Complement activation by polyclonal immunoglobulin IgG1 and IgG2 antibodies against Staphylococcus aureus. Infect Immun. 60:4838-4847.
35. Dozio N, Belloni C, Girardi A, et al. 1994 Heterogeneous IgG subclass distribution of islet cell autoantibodies. J Autoimmun. 7:45-53.
36. Richter W, Seissler J, Northemann W, Wolfahrt S, Meinck HM, Scherbaum WA. 1993 Cytoplasmic islet cell antibodies recognise distinct islet antigens in type 1 diabetes but not in stiff man syndrome. Diabetes. 42:1642-1648.
37. Hallberg A, Juhlin C, Berne C, Kampe O, Karlsson FA. 1995 Islet cell antibodies: variable immunostaining of pancreatic islet and carcinoid tissue. J Intern Med. 238:207-213.
38. Daw K, Ujihara N, Atkinson M, Powers AC. 1996 Glutamic acid decarboxylase autoantibodies in stiff man syndrome and insulin dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol. 156:818-825.